NDC 53002-2630

Ella

Ulipristal Acetate

Ella is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is Ulipristal Acetate.

• Product ID: 53002-2630_28822df7-626a-43a0-8648-7ca0cc7b5c0a
• NDC: 53002-2630
• Product Type: Human Prescription Drug
• Proprietary Name: Ella
• Generic Name: Ulipristal Acetate
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2020-05-11
• Marketing Category: NDA /
• Application Number: NDA022474
• Labeler Name: RPK Pharmaceuticals, Inc.
• Substance Name: ULIPRISTAL ACETATE
• Active Ingredient Strength: 30 mg/1
• Pharm Classes: Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 53002-2630-1

1 BLISTER PACK in 1 CARTON (53002-2630-1) > 1 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2022-08-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Ella" or generic name "Ulipristal Acetate"

NDC	Brand Name	Generic Name
50090-2835	Ella	ulipristal acetate
50090-5422	Ella	ulipristal acetate
50102-911	Ella	ulipristal acetate
53002-1630	Ella	ulipristal acetate
53002-2630	Ella	ulipristal acetate
73302-456	Ella	ulipristal acetate
82454-0456	Ella	ulipristal acetate